Fragmento

Antiviral activity of the on-nucleoside polymerase inhibitor, HCV-796, in patientes with chronic hepatitis C virus: preliminary results from a randomized, double-blind, placebo-controlled, ascending multiple dose study.- Chandra P, et al. Clinical Pharmacology, Wyeth Research, Collegeville, PA, USA. Association of interferon signaling pathway and interferon stimulated genes with response to pegylated interferon and ribavirin therapy in HCV Infected caucasian and African American patients.- Su X, et al. Medical Genetics, Cedars-Sinai Medical Center, Los Angeles, CA, USA. Late onset Wilson disease (WD). Ferenci P. Internal Medicine 4, Medical University of Viena, Wien, Austria. Detection od caspase activity in the blood of patients with nonalcoholic fatty liver disease as a novel biomarker of disease severity.- Wieckowska A, et al. Gastroenterology and Hepatology. Cleveland Clinic Foundation. Cleveland, OH, USA. PARA ESTA INFORMACIÓN SUGERIMOS DESCARGAR FORMATO PDF.

Palabras clave:

2006-11-08   |   964 visitas   |   7 valoraciones

Vol. 71 Núm.1. Agosto 2006 Pags. 127-129 Rev Gastroenterol Mex 2006; 71(Supl. 1)